Pfizer was riding high during the pandemic but has been overtaken by rivals including Eli Lilly and Novo Nordisk whose weight ...

Chronic stress speeds colorectal cancer's spread dramatically by disrupting gut microbiota -- the delicate balance of good ...

In this age of over-consumption, ironically capitalism is a hated word, as are the capitalists. In these excerpts, John Kay ...

We recently published a list of 8 Stocks Under $20 To Invest In Now. In this article, we are going to take a look at where ...

Researchers at Massachusetts General Hospital have discovered that meeting the weekly recommended physical activity levels, ...

Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors - making it the first antitissue-factor pathway inhibitor to be allowed for the ...

The bull market has had a variable impact for stocks across a range of industries the last few years. While some companies have ridden the bull market waves, others have retreated or been beaten down ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.